Ligand binding determinants for angiotensin II type 1 receptor from computer simulations
Minos-Timotheos Matsoukas1, Arnau Cordomí, Santiago Ríos
1Department of Chemistry, University of Patras , GR-26504, Rion, Patras, Greece.
Journal of Chemical Information and Modeling
|October 5, 2013
Summary
Computer simulations revealed how sartans bind to the angiotensin II type 1 receptor (AT1R). This study clarifies the molecular interactions between AT1R and sartan drugs, crucial for understanding their therapeutic effects.
Area of Science:
- Pharmacology
- Computational Chemistry
- Structural Biology
Background:
- The angiotensin II type 1 receptor (AT1R) is a key target for treating cardiovascular diseases.
- Understanding AT1R ligand binding is crucial for developing effective therapeutics.
- G protein-coupled receptors (GPCRs) are a major class of drug targets.
Purpose of the Study:
- To characterize the ligand binding determinants of the AT1R.
- To elucidate the molecular mechanisms of sartan interaction with AT1R.
- To combine computational modeling with simulation data to explain drug-receptor interactions.
Main Methods:
- Generation of a pharmacophore model for AT1R ligands.
- Construction of an AT1R structural model using GPCR crystal structures.
- Molecular docking of AT1R ligands.
- Molecular dynamics (MD) simulations of ligand-receptor-lipid bilayer systems.
- Binding free energy calculations.
Main Results:
- A pharmacophore model accurately represented known AT1R ligands with varying affinities.
- Docking studies based on the pharmacophore model predicted ligand-receptor interactions.
- MD simulations provided insights into the dynamic behavior of the ligand-receptor complex within a lipid bilayer.
- Combined analysis proposed specific molecular mechanisms for sartan binding to AT1R.
Conclusions:
- The study successfully integrated pharmacophore modeling and MD simulations to understand AT1R ligand binding.
- The proposed molecular mechanisms provide a basis for rational drug design targeting AT1R.
- This computational approach offers valuable insights into GPCR-ligand interactions.
Related Concept Videos
02:40Ligand Binding Sites
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
02:40Ligand Binding Sites
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
00:49Ligand Binding and Linkage
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence the...
01:49Conserved Binding Sites
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
02:18The Equilibrium Binding Constant and Binding Strength
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium: